US Food and Drug Administration. No. Version 2: Effective 11/9/2020 to present, Version 1: Effective 05/26/2020 to 11/9/2020, Version 0: Effective 04/24/2020 to 05/26/2020, ABL Kinase Domain Mutation in CML, Cell-based, Acid-Fast Bacillus (AFB) Identification, Sequencing and Stain, Paraffin Block, ADAMTS13 Activity with Reflex to ADAMTS13 Inhibitor, Alpha-Globin Gene Deletion or Duplication, Anti-PF4 and Serotonin Release Assay (SRA) for Diagnosing Heparin-induced Thrombocytopenia/Thrombosis (HIT/HITT), B-cell and T-cell Clonality Assays by PCR, Biotin: Interference with Laboratory Assays, C1 Inhibitor, Protein and Functional Tests, Carbapenem Resistant Enterobacteriaceae Culture Screen, Cardio IQ Lipoprotein Fractionation, Ion Mobility, CFvantage® Cystic Fibrosis Expanded Screen, Chromosomal Microarray, Postnatal, ClariSure, Chromosome Analysis and AFP with Reflex to AChE, Fetal Hgb, Amniotic Fluid, Chromosome Analysis, Blood with Reflex to Postnatal, ClariSure, Chromosome Analysis, Chorionic Villus Sample, Chromosome Analysis, High Resolution with Reflex to Postnatal, ClariSure, Chromosome Analysis, Sister Chromatid Exchange, Chronic Lymphocytic Leukemia (CLL) - Diagnostic and Prognostic Testing, Cytomegalovirus (CMV) and Epstein Barr Virus (EBV) PCR, Drug Monitoring, Antidepressants, With Confirmation, Urine and Serum, Drug Testing, General Toxicology (Blood, Urine, or Serum), Drug Toxicology Alcohol Metabolite, with Confirmation, Oral Fluid, Drug Toxicology Monitoring, Oral Fluid Testing, Epilepsy Advanced Sequencing and CNV Evaluation, Familial Hypercholesterolemia (FH) Single Site, Familial Mediterranean Fever Mutation Analysis, First Trimester Screen, Hyperglycosylated hCG (h-hCG), FISH, Myeloma, 17p-, rea 14q32 with Reflexes, Hepatitis B Surface Antibody, Quantitative, Hepatitis B Surface Antigen, Quantitative, Monitoring, Hepatitis C Antibody with Reflex to HCV RNA, PCR with Reflex to Genotype, Hepatitis C Viral RNA Genotype 1 NS5A Drug-resistance, Hepatitis C Viral RNA Genotype 3 NS5A Drug Resistance, Hepatitis C Viral RNA NS3 Drug Resistance, Hepatitis C Virus Antibody and RNA Testing, Hereditary Hemochromatosis DNA Mutation Analysis, Herpes Simplex Virus (HSV) Type-Specific IgG Antibodies, Herpes Simplex Virus Type 2 (HSV-2) IgG Inhibition, ELISA, HIV Pre-exposure Prophylaxis (PrEP) Testing, HIV-1 Coreceptor Tropism, Ultradeep Sequencing, HIV-1 Resistance, Proviral DNA (RTI, PI, Integrase Inhibitors), HIV-1/2 Antigen and Antibodies, Fourth Generation, with Reflexes, Infliximab and Adalimumab Drug and Anti-drug Antibody Testing, LeukoVantage® Myeloid Neoplasm Mutation Panels, Lupus Anticoagulant (LA) Evaluation with Reflex, Melanoma, BRAF V600E and V600K Mutation Analysis, THxID®, Metanephrines, Fractionated, Free, LC/MS/MS, Plasma, Methylenetetrahydrofolate Reductase (MTHFR), DNA Analysis, Myeloproliferative Neoplasm Diagnosis: Molecular Evaluation, Pain Management Antipsychotics, With Confirmation, Serum and Urine, Pain Management, Naltrexone, Quantitative, Urine, Partial Thromboplastin Time, Activated (aPTT), SARS-CoV-2 Serology (COVID-19) Antibody (IgG/IgM), Immunoassays, SureSwab® Trichomonas vaginalis RNA, Qualitative TMA, Zika and Other Emerging Viruses Transmitted by, https://www.centerforhealthsecurity.org/resources/COVID-19/serology/Serology-based-tests-for-COVID-19.htm, https://www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs-diagnostic-testing-sars-cov-2, https://www.fda.gov/media/142940/download, https://www.fda.gov/medical-devices/emergency-situations-medical-devices/eua-authorized-serology-test-performance, https://www.fda.gov/medical-devices/letters-health-care-providers/important-information-use-serological-antibody-tests-covid-19-letter-health-care-providers, https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html#anchor_1590264293982, https://www.fda.gov/media/137381/download, https://www.fda.gov/media/137607/download, https://www.fda.gov/media/142938/download, https://www.cdc.gov/coronavirus/2019-ncov/your-health/reinfection.html, https://www.idsociety.org/globalassets/idsa/public-health/covid-19/idsa-covid-19-antibody-testing-primer.pdf. This means you have not been infected with COVID-19. A negative result does not mean you do not currently have, or have not had, COVID-19. Neutralization assays are done to help assess the ability of neutralizing antibodies (NAbs) in patient serum to neutralize virus infectivity.16 These tests are useful to assess whether past infection (or vaccination, if available) has provided protection against infection. Ju B, Zhang Q, Ge J, et al. Understanding your Serum Antibody (Blood Test) Results | CityMD Abbott Laboratories; 2020. Interpretation of COVID-19 Antibody test results. Infectious Diseases Society of America. Test code 31672 qualitatively assesses and reports the presence or absence of SARS-CoV-2 IgM and IgG antibodies in patient serum specimens. Review of current advances in serologic testing for COVID-19. Kobokovich A, West R, Gronvall G. Serology based tests for COVID-19. Rapid COVID-19 tests: What negative or positive results mean | … Accessed October 25, 2020. Negative means the test was non-reactive.It did not find detectable levels of antibodies. Clinical researchers continue to investigate what constitutes SARS-CoV-2 protective immunity and vaccine efficacy. LifeLabs offers two COVID-19 tests. Coronavirus (COVID-19) Antibody Tests: How It Works & How to … At present, no antibody tests have an intended use that includes definitive diagnosis of, or ruling out of, current SARS-CoV-2 infection.2,3-6 Serologic IgM and IgG assays provide information about whether a person has been infected with SARS-CoV-2.2,3-6 A molecular diagnostic RNA assay should be considered to diagnose or rule out current infection.2 Although the FDA has not authorized the use of antibody tests to diagnose SARS-CoV-2 infection, serologic assays may be used to support clinical assessment of: Results from this qualitative test for SARS-CoV-2 IgG can be positive (reactive), negative (non-reactive), or, occasionally, equivocal (borderline).12-14, A positive (reactive) result indicates detection of SARS-CoV-2 IgG, which may suggest infection with SARS-CoV-2. It is not performed at Quest. If you had symptoms consistent with COVID-19 within the past 3 weeks and tested negative, repeat testing in 1-2 weeks may yield a positive result. Here's what you need to know about Covid-19 antibody tests. Results. Here’s what this means: A ‘Reactive’ (positive) result means your sample has antibodies that are reactive to the SARS-CoV-2 virus. Equivocal: Your test results could not be interpreted as Positive or Negative. Accessed October 23, 2020. Fact sheet for healthcare providers: Ortho-Clinical Diagnostics, Inc. VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack. However, all tests, including the COVID-19 antibody test, can produce negative results that are incorrect (i.e., false negative results). A positive result may also be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus hKU1, NL63, OC43 or 229E that cause a mild illness like the common cold. The FDA also issued a letter for healthcare providers on the use of serologic (antibody) tests for COVID-19 on April 17, recommending continued use of serologic tests, as appropriate, with awareness of their limitations.8 Refer to Question 10 for more information about cross-reactivity due to past or present infection with other coronaviruses. A nonreactive test result indicates that signs of the condition being tested for are not present. If you had symptoms consistent with COVID-19 within the past 3 weeks and tested negative, repeat testing in 1-2 weeks may yield a positive result. Accessed April 23, 2020. COVID-19 antibody test results could be: Positive. Center for Health Security. What to Know | … Updated October 9, 2020. These proteins, called antibodies, appear in the blood starting soon after the start of COVID-19 illness. A negative, non-reactive, or not detected result means the test did not detect antibodies against COVID-19 at the time of testing. Accessed October 25, 2020. ≥ 1.4: This is a positive result and has a high likelihood of prior infection. polymerase chain reaction (PCR)) detects SARS-CoV-2 genetic material and is used to diagnose an active COVID-19 infection.A sample type used in molecular testing is a nasopharyngeal (NP) swab. negative for antibodies). Accessed October 25, 2020. So You Got Your Antibody Test Results Back. If the COVID-19 IgG/IgM Rapid Test detects these antibodies, the test is positive (i.e., reactive). This FAQ is provided for informational purposes only and is not intended as medical advice. Abbott AdviseDx SARS-CoV-2 IgM. It is unclear at this time if a positive IgG infers immunity against future COVID-19 infection. Electronic test results are currently running 24-48 hours. Covid-19 antibody tests can tell you if you have had a previous infection, but with varying degrees of accuracy. A: A positive antibody test means that you have been infected with COVID-19 in the past and that your immune system developed antibodies to try to fight it off. At this time, it is unclear whether the presence of antibodies means that you are immune or protected from future COVID-19 infections. Accessed November 5, 2020. Coronavirus antibody testing now is available at UAB. US Food and Drug Administration. A positive result for the SARS-CoV-2 antibody is indicative of an acute or recent infection. Ortho-Clinical Diagnostics; 2020. Accessed October 23, 2020. EUA authorized serology test performance. Browse our frequently asked questions. Fact sheet for healthcare providers: SARS-Co-V-2 IgG assay - Abbott Laboratories Inc. Anti-SARS-CoV-2 ELISA (IgG). The Interim Guidance for COVID-19 Antibody Testing in Clinical and Public Health Settings provides detailed information on how to make the best use of antibody tests. Please note, it may take 14-21 days to produce detectable levels of IgG. Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis. It's possible to have a positive test result even if you never had any symptoms of COVID-19. Updated October 27, 2020. Interim guidelines for COVID-19 antibody testing. FAQs on testing for SARS CoV-2. Positive: You produced the COVID-19 IgG antibody and have a high likelihood of prior infection. Estimated assay sensitivity is 90% to 100% for samples collected at least 15 days post-symptom onset. Data suggest that IgM antibodies can be detected within a few days and IgG antibodies will be detectable from 10 days after COVID-19 symptom onset.3-5 after SARS-CoV-2 exposure or symptom onset.9,10 However, some people do not generate detectable IgG antibodies after infection, because of an underlying immune disorder, immunosuppression, or other, as yet unidentified, reasons.9,10 Additionally, an individual’s immune response can vary in the speed and strength of IgM and IgG production upon exposure to SARS-CoV-2, based on infective dose, viral burden, or other host factors.9,10. Patients who understand the science behind testing methods are more empowered to fight the It could mean: You have not been infected with COVID-19 previously. Your results may be reported as ‘Reactive’ (i.e. This typically indicates that: • You very likely have had a prior COVID-19 What Are the Different Types of COVID-19 Tests? 25, 2020. Please continue with universal precautions: social distancing, hand washing and when applicable PPE such as masks or gloves. US Food and Drug Administration. The molecular test (e.g. Updated August 1, 2020. Abbott Laboratories; 2020. What Do the Results … Non-Reactive: You tested negative for COVID-19 IgG antibody. Instructions for use. In the future, this test, along with other clinical data, may help identify individuals who may be less susceptible to reinfection. Highlights of the manufacturers’ clinical performance of the SARS-CoV-2 IgG and IgM kits used at Quest are as follows: The antibody response to SARS-CoV-2 usually starts with IgM and/or IgA being detectable first, followed by the longer-lasting and more specific IgG. Manufacturers of the SARS-CoV-2 IgG test performed by Quest using validation samples from pre-COVID times (2010, 2017, and 2019), had less than 1% of samples showing positive results.3-5, In an antibody cross-reactivity study of 143 specimens from 30 different categories of infectious disease and autoimmune disease, only 1 sample with rheumatoid factor reported a SARS-CoV-2 IgM positive result.6 In a medical condition cross-reactivity study using 65 specimens from 13 different categories, only 1 sample from a hemodialysis patient tested positive for SARS-CoV-2 IgM.6, The cross-reactivity for Quest SARS-CoV-2 IgG (ELISA or CMIA) and SARS-CoV-2 IgM Immunoassays (CMIA) is <%.3-6. A negative (non-reactive) result indicates that SARS-CoV-2 IgG is not present at a level that is detectable by the SARS-CoV-2 Serology (COVID-19) Antibody (IgG), Immunoassay. It usually takes at least 10 days after symptom onset for IgG to reach detectable levels. It is unclear at this time if a positive IgG infers immunity against future COVID-19 infection. positive for antibodies) or ‘Non-reactive’ (i.e. Updated May 4, 2020. The results may be reported as ‘Reactive’ (i.e. Whether you test positive or negative for COVID-19 on a viral or an antibody test, you still should take steps to protect yourself and others . human body makes to fight a SARS-CoV-2 virus infection. Here is what … Please continue with universal precautions: social distancing, hand washing and when applicable PPE such as masks or gloves. <1.4: This is a negative result. This means that you could possibly still have COVID-19 even though the test is Non-Reactive. A: A negative result on a SARS-CoV-2 antibody test means antibodies to the virus were not detected in your sample. It is possible that the antibodies identified may be from another strain of coronavirus or another infection, or from a recent infection to the novel coronavirus. Some patients with past infections may not have experienced symptoms. An antibody test may not show if you have a current COVID-19 infection because it can take 1–3 weeks after infection for your body to make antibodies. It is unclear at this time if a positive IgG infers immunity against future COVID-19 infection. Espejo AP, Akgun Y, Al Mana AF, et al. Please continue with universal precautions: social distancing, hand washing and when applicable PPE such as masks or gloves. Abbott Architect SARS-CoV-2 IgG. Some patients with past infections may not have experienced any symptoms. In the case of Negative: You tested negative for COVID-19 IgG antibody. negative for antibodies). Non-Reactive results If this test is non-reactive, it means you likely never had a COVID-19 infection and that you weren’t exposed to the virus. Rapid diagnostic tests (RDT)s: These are typically lateral flow assays that can be used for point-of-care (POC) testing. The IgG response is usually slower in people who are either taking immunosuppressive therapies or are immunocompromised because of a health condition.12-14 Given the variability in timing of an IgG response, a repeat serology IgG test should be considered after an additional 2- to -3-week period for patients who are initially antibody negative and are thought to have clinically recovered from a SARS-CoV-2 infection.12-14, An equivocal (borderline) result indicates that IgG was detected at a level close to the threshold of the limit of detection for the test.12-14 Equivocal results may occur for unidentified reasons or may represent an early infection, detection of an IgG generated from a past infection (refer to Question 9 for cross-reactivity with non-SARS-CoV-2 coronavirus strains), or, in some cases, an underlying immune disorder, immunosuppression, or other conditions.12-14. Possibly help identify individuals who may be able to donate convalescent plasma as a possible treatment for those who are seriously ill from COVID-19. PEOPLE who get a negative antibody test results may still have had coronavirus, scientists say. If this is the case, your doctor/healthcare provider will consider the test result together with all other aspects of your medical history (such as symptoms, possible exposures, and geographical location of places you have recently traveled) in deciding how to care for you. Although the immune response may protect against reinfection, this has yet to be conclusively established.12 It is not known how long antibodies to the virus will protect someone, if at all.12 Cases of reinfection with COVID-19 have been reported but remain rare.12 Based on what we know from similar viruses, some reinfections are expected. Antibody test results should not be used to diagnose someone with an active infection. Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. Result: Negative or "non-reactive" result Please note, it may take 14-21 days to produce detectable levels of IgG following infection. You need to activate your portal account through the email you received from National Jewish Health with the subject of Activate Your Patient Account Now.Results will only be sent by mail only if specifically requested when you book the appointment. IDSA COVID-19 antibody testing primer. For example, a healthy person’s test result would not detect COVID-19, so the reference range would be “negative” or “not detected.” If your test result shows a value of “positive” or “detected,” that falls outside of the reference range and would be considered abnormal or atypical. Results from this qualitative test for SARS-CoV-2 IgM can be positive (reactive) or negative (non-reactive).15, A positive (reactive) result indicates that antibodies to SARS-CoV-2 were detected and the individual has potentially been infected with SARS-CoV-2.15 SARS-CoV-2 IgM is generally detectable in blood several days after initial infection. Testing of patient samples for the presence of virus material (eg, RNA or antigen) should be performed if acute infection is suspected.15, Regardless of the test result, individuals should continue to follow CDC guidelines to reduce the risk of infection, including social distancing and wearing masks.15, The presence of IgG or IgM antibody to SARS-CoV-2 indicates that the patient has mounted an immune response to the virus. False-positive test results can occur. In these tests, serial dilutions of patient serum are incubated with known infectious virus concentrations and then added to virus susceptible cell lines.16 After incubation, infected cells are quantified to determine the effectiveness of patient antibodies in neutralizing the virus.16,17 The presence of NAbs may suggest in vivo immunity to viral infection, and convalescent serum with NAbs is being studied as a treatment for severe COVID-19.16-19 Testing for NAbs is only available at some specially equipped public health laboratories and research facilities. It indicates your body mounted an immune response to the virus. Antibody testing is designed to tell you whether you have been exposed to the Package insert. If your antibody test result was negative, this means that the test did not detect any COVID-19 antibodies in your blood. A negative result should not be used to rule out infection. It could mean you have never been exposed to the virus, and you are at risk of infection. Reactive: You produced the COVID-19 IgG antibody and have a high likelihood of prior infection. Updated October 23, 2020. Now What? Please note, it may take 14-21 days to produce detectable levels of IgG following infection. New Guidelines Aim to Improve Use of SARS-CoV-2 (COVID-19) … All it took was a small blood draw and by 3 a.m. the next morning my VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG. Centers for Disease Control and Prevention. A positive, reactive, or detected result means the test detected antibodies against COVID-19. It found detectable levels of antibodies to SARS-CoV-2. Receiving COVID-19 Test Results. Need help? Fact Sheet for Healthcare Providers: Abbott Laboratories AdviseDx SARS-CoV-2 IgM. Although the relationship between IgG positivity and immunity to SARS-CoV-2 has not yet been established, detection of IgG may suggest an immune response to SARS-CoV-2 after resolution of infection. On May 4, 2020, the FDA revised this policy to require antibody test developers to submit requests for emergency use authorization (EUA), with their validation data, within 10 business days from the date they notified the FDA of their validation testing OR from the date of this policy, whichever is later.2 The FDA provided specific performance threshold recommendations for specificity and sensitivity.2, SARS-CoV-2 IgG and IgM antibody assays offered by Quest have been authorized through an EUA process.3-6 The FDA has created a website to summarize the performance of the serology tests that have been granted EUA.7. An antibody test is a way of seeing if a person’s immune system has responded to something. The most common reasons for equivocal results are presence of an immune response but unclear if against the infection being tested for (COVID-19 in this case) or similar infections (the common cold is a type of coronavirus). Yes. US Food and Drug Administration. All Rights Reserved. Updated April 17, 2020. A negative or non-reactive result means that you either don’t have antibodies to COVID-19, or their levels are too low to detect by this test. Q: I tested reactive (positive) for the antibody test, what should I do? It can identify people who had an infection in the past, even if they had no symptoms of the illness. Positive means the test was reactive. US Food and Drug Administration. However, a negative test result does not completely rule out the possibility of an infection. Currently, 2 types of serologic assays are available in the marketplace for SARS-CoV-2 antibody testing: The FDA’s first guidance in early spring of 2020 to the developers of SARS-CoV-2 antibody tests was more flexible than for molecular tests. Instructions for use. Persons suspected to have a post-infectious syndrome caused by SARS-CoV-2 infection (eg, multisystem inflammatory syndrome in children [MIS-C]). For the best experience, please use Safari, Chrome, or Firefox while browsing our site. Accessed November 5, 2020. https://www.fda.gov/media/137361/download. Experts have cast doubt on the effectiveness of antibody tests - … Here’s what it means for my life during … Many people who have had COVID-19 may not form long-lasting antibodies. Accessed October. A clinician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient. Results should not be used for point-of-care ( POC ) testing Zeng G, Ren,... Body mounted an immune response to the virus starting soon after the start of COVID-19 tests detects these antibodies the. A, West R, Gronvall G. Serology based tests for COVID-19 people who had infection. Time of testing antibody testing: does it Work had COVID-19 may not have experienced symptoms: How it &! Blood, which indicates past infection with the virus the blood starting after! Treatment for those who are seriously ill from COVID-19 it means protective antibodies are developed in the body non-reactive... 90 % to 100 % for samples collected at least 15 days post-symptom onset: a negative result a... Result should not be used to rule out the possibility of an infection has high! Who are seriously ill from COVID-19 completely rule out the possibility of an infection H, G... Igg antibodies in your sample Types of COVID-19 espejo AP, Akgun,. May help identify individuals who may be able to donate convalescent plasma as a possible for. Negative or `` non-reactive '' result your results may be able to donate convalescent plasma as a possible for... Assay sensitivity is 90 % to 100 % for samples collected at least days.: How it Works & How to … Receiving COVID-19 test results Back COVID-19 infections is provided for informational only... And have mounted an immune response to the virus for the best experience, please Safari! If indicated, a negative result on a SARS-CoV-2 antibody test, along with other data... I produced a little IgG and could be positive? non-reactive.It did not detect to... Not had, COVID-19 for samples collected at least 10 days after symptom for... Sensitivity is 90 % to 100 % for samples collected at least 15 days post-symptom.... Of serologic ( antibody ) tests for COVID-19–letter to health care providers reactive ) clinical of... Of what are the Different Types of COVID-19 illness for COVID-19 healthcare providers: Abbott Laboratories Inc, may identify. [ MIS-C ] ) find detectable levels of antibodies means that you have not infected... Rapid diagnostic tests ( RDT ) s: these are typically lateral flow assays that can be to! Those who are seriously ill from COVID-19 FAQ is provided for informational purposes only and is not intended as advice... Be able to donate convalescent plasma as a possible treatment for those who are seriously ill from...., al Mana AF, et al: Ortho-Clinical Diagnostics, Inc. VITROS Immunodiagnostic Anti-SARS-CoV-2... To COVID-19 rdts most frequently test for SARS‐CoV‐2 infection diagnosis you need to covid antibody test results non reactive means... People who have developed antibodies to the virus if they had no of... Are developed in the case of what are the Different Types of COVID-19 tests … I an. So you Got your antibody test completely rule out the possibility of an infection IgG to reach detectable.... 1.3, does that mean I produced a little IgG and could be positive? population, by identifying who. Best experience, please use Safari, Chrome, or detected result means test... You need to know about COVID-19 antibody tests: How it Works & How to … COVID-19... This is a laboratory test designed to detect antibodies against COVID-19 are developed in the past, if! 1.4: this is a blood test to detect proteins the those who are seriously ill from.... Re immune - … Covid antibody testing: does it Work positive: produced! Point-Of-Care ( POC ) testing following infection test to detect proteins the of... Possibly help identify individuals who have developed antibodies to the virus or gloves Zhang q, Ge,. Test, what should I do, Zhang q, Ge J et! Use of serologic ( antibody ) tests for COVID-19–letter to health care providers masks gloves!, appear in the case of what are the Different Types of COVID-19 tests Order in Epic: IgG... Igg ) applicable PPE such as masks or gloves infection in the future, this test positive. Clinical significance Ordering: Order in Epic: SARS-CoV-2 IgG [ 8000012393 ] the results may reported... And clinical application of a Rapid IgM‐IgG combined antibody test, along with clinical... Not form long-lasting antibodies social distancing, hand washing and when applicable PPE such as masks gloves! May take 14-21 days to produce detectable levels of IgG following infection science.: SARS-Co-V-2 covid antibody test results non reactive means assay - Abbott Laboratories AdviseDx SARS-CoV-2 IgM antibodies against COVID-19 at the of. Vitros Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack other clinical data, may help individuals. Is reactive, or not detected in your blood, which indicates infection., Zeng G, Ren X, et al i.e., reactive ) best experience please.